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Abstract
The practice of an infectious diseases (ID) physician is evolving. A contemporary understanding of the frequency and variety of patients and
syndromes seen by ID services has implications for training, service development and setting research priorities. We performed a 2-week
prospective survey of formal ID physician activities related to direct inpatient care, encompassing 53 hospitals throughout Australia, New
Zealand and Singapore, and documented 1722 inpatient interactions. Infections involving the skin and soft tissue, respiratory tract and bone/
joints together accounted for 49% of all consultations. Suspected/conﬁrmed pathogens were primarily bacterial (60%), rather than viral
(6%), fungal (4%), mycobacterial (2%) or parasitic (1%). Staphylococcus aureus was implicated in 409 (24%) episodes, approximately four times
more frequently than the next most common pathogen. The frequency of healthcare-related infections (35%), immunosuppression (21%),
diabetes mellitus (19%), prosthesis-related infections (13%), multiresistant pathogens (13%) and non-infectious diagnoses (9%) was high,
although consultation characteristics varied between geographical settings and hospital types. Our study highlights the diversity of
inpatient-related ID activities and should direct future teaching and research. ID physicians’ ability to offer beneﬁcial consultative advice
requires broad understanding of, and ability to interact with, a wide range of referring specialities.
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The practice of an infectious diseases (ID) physician is evolving
from a primarily academic speciality based in large teaching
hospitals to practice in more diverse settings [1]. However,
training and research priorities are often set by academic
physicians based at large teaching centres, and the clinical
proﬁle at these hospitals may not reﬂect that seen by the
wider workforce. To date, most studies of ID consultative
activity have been retrospective in design and describe the
experience of a single centre [2–4] or comparisons of two
practice settings [5–7]. The only published prospective
nationwide study of ID physician activity was undertaken in
Canada more than two decades ago and therefore may not
reﬂect the current challenges faced by our profession [1]. We
aimed to prospectively measure the frequency and diversity of
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formal inpatient-related activities undertaken by ID physicians
across three countries over a 2-week period.
Methods
Setting
ID training is conducted under the auspices of the Royal
Australasian College of Physicians (RACP), with training
opportunities available in Australia, New Zealand and Singa-
pore. ID registrars in training typically work for 3 years at
hospitals with at least 1.0 full-time equivalent ID physician. In
all three countries, the majority of secondary and tertiary
healthcare is delivered by hospitals funded or subsidized
primarily by government (‘public hospitals’), with a smaller
proportion delivered by hospitals funded from private health
insurance (‘private hospitals’). All three countries are highly
urbanized but only ﬁve Australian cities, the city/nation of
Singapore and Auckland, New Zealand, have more than a
million inhabitants. Paediatric care is delivered by specialist
paediatricians in referral paediatric hospitals as well as general
hospitals serving both adult and paediatric patients.
Study design
We conducted a survey of ID physicians’ activity related to
direct inpatient care. Respondents were recruited at the
Australian Society for Infectious Diseases (ASID) annual
meeting and via an established mailing list of ID physicians.
A web-based data entry system (Survey Monkey, Palo Alto,
CA, USA) was developed to collect de-identiﬁed data from
hospitals in Australia, New Zealand and Singapore over a
14-day period in August 2012. One or more ID registrars or
physicians were registered as respondents in each participat-
ing hospital. They completed an on-line form comprising
demographics and clinical details for every patient seen who
met the criteria for formal ID consultation or ID inpatient
admission.
Deﬁnitions
A formal ID consultation had to fulﬁll the following criteria: (i)
a consultation was requested by another inpatient team or by
local institutional rules (e.g. the prescription of restricted or
expensive antimicrobial agents automatically triggered an ID
consult); (ii) an ID registrar and/or physician examined the
patient and made a medical record entry. An ID inpatient
admission was deﬁned as a patient being admitted or
transferred under the care of an ID physician either within
an inpatient ward or within a Hospital in the Home (HITH)
unit (equivalent to Outpatient Parenteral Antimicrobial Ther-
apy). Only the ﬁrst episode of care was counted for any given
patient during the study period. Patients were excluded in the
following situations: (i) telephone advice only, (ii) informal
consultations where the patient was not seen, (iii) outpatient
clinics, (iv) antibiotic stewardship rounds or antibiotic approv-
als, and (v) other regular ID advisory rounds (e.g. in the
Intensive Care Unit (ICU) or transplant wards). Immunosup-
pression was considered present if the patient was receiving
immunosuppressive therapy (including the equivalent of
≥0.5 mg/kg/day of prednisone, monoclonal antibodies or other
biological agents or cytotoxic chemotherapy), or had a primary
immunodeﬁciency disorder, hyposplenism or human immuno-
deﬁciency virus (HIV).
Infections were deﬁned as either community onset,
non-healthcare-associated (onset <48 h since admission to
hospital), community onset, healthcare associated (onset
<48 h since admission to hospital but contact with HITH,
haemodialysis or outpatient chemotherapy within last 30 days,
hospital admission within the last 90 days, or living in a
long-term care facility) or nosocomial (onset ≥48 h after
admission to hospital) [8]. In Australia, regional (vs. metro-
politan) hospitals were deﬁned as those located outside of
state/territory capital cities. In New Zealand, metropolitan
hospitals were deﬁned as those providing a broad range of
tertiary level services. Paediatric patients were deﬁned as
those ≤16 years of age. Foci of infection were classiﬁed into
categories corresponding to the Australian national antibiotic
prescribing guidelines [9].
Statistical methods
Each patient was labelled with a unique code which identiﬁed
the respondent, the hospital and a non-identiﬁable number for
the patient. Data were analysed using Stata 12.1 (Statacorp,
College Station, TX, USA). Continuous data were summarized
using median and interquartile range and were compared using
the Mann–Whitney U-test. p <0.05 was considered signiﬁcant.
Ethical approval
In Australia, approval was obtained from the ethics committee
of the Northern Territory Department of Health and the
Menzies School of Health Research (HOMER-2011-1638), with
letters of support from directors of each participating
department. Multi-site ethical approval was obtained in New
Zealand (MEC/12/EXP/028) and Singapore (NHGDSRB 2012/
00455).
Results
Ninety-one ID physicians at 53 hospitals participated in the
survey, including 36 of the 53 (68%) RACP-accredited training
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sites. Table 1 describes the characteristics of the participating
hospitals. The proportion of hospitals with speciality units
were: HITH (91%), haematology/oncology (81%), paediatrics
(74%), cardiothoracic surgery (62%), HIV (53%), trauma (49%),
cystic ﬁbrosis (42%), haematological stem cell transplant (42%),
solid organ transplant (38%) and burns (23%).
A total of 1722 inpatient interactions were documented
(Table 2). The mean patient age was 51 years (range
<1 month to 98 years) and 214 (12%) were ≤16 years of
age; there was a male preponderance (n = 1047; 61%). One
hundred and seventy-two of the patients (10%) were of South
East Asian ethnicity, 112 (7%) were Indian, 81 (5%) indigenous
Australians, 81 (5%) indigenous New Zealander/Paciﬁc Island-
ers and 14 (1%) were African, with the remainder being
Caucasian. Only 67 (3.9%) patients were HIV positive, but a
substantial proportion had some form of immunosuppression
(n = 361, 21.0%), or diabetes mellitus (n = 323, 18.8%).
Activity consisted of 1435 (83%) new ID consultations, 196
(11%) new ID inpatient admissions and 91 (5%) new HITH
admissions. The three most common foci of infection (skin and
soft tissue, respiratory bone/joint) together accounted for 49%
of all consultations. The ﬁfth most common category was
non-infectious and most commonly included adverse drug
reactions, autoimmune inﬂammatory conditions, venous
thromboembolism and malignancy.
Metropolitan hospitals had a lower proportion of referrals
from general medicine, and had a higher proportion of patients
with HIV or who were immunosuppressed (Table 2). Differ-
ences were seen between countries in the proportions of
patients referred from the emergency department, general
surgery and ICU, in the proportions of patients with diabetes,
HIV or immunosuppression and infections involving prosthetic
material, and in the proportions of patients with multi-
drug-resistant pathogens. Although data on only 42 patients
in private hospitals were collected, differences were evident,
with a higher proportion of referrals from orthopaedic units
(21% vs. 11%, p 0.04) and oncology (21% vs. 3%, p <0.001) and
more patients with skin/soft tissue infection (36% vs. 19%,
p 0.02) than in public hospitals.
Compared with the paediatric setting (n = 214), a higher
proportion of adult patients had HIV (4% vs. 0.5%, p 0.002),
diabetes (21% vs. 0.5%, p <0.001) or immunosuppression (22%
vs. 14%, p 0.01). More paediatric patients had systemic
infection (19% vs. 13%, p 0.03), central nervous system
infection (11% vs. 4%, p <0.001) and infections due to viral
pathogens (11% vs. 5%, p 0.003), whereas a higher proportion
of adult patients had cardiovascular infection (5% vs. 1%,
p 0.003).
The majority of consultations concerned bacterial patho-
gens (n = 1034; 60%), with viral, fungal, mycobacterial and
parasitic infections less frequent (6%, 4%, 2% and 1%,
respectively). By far the most commonly suspected or
conﬁrmed pathogen was Staphylococcus aureus (n = 409,
24%), which was implicated approximately four times more
frequently than the next most common pathogen (Table 3).
Multiresistant organisms were suspected or conﬁrmed in 13%
of all patients seen, and most commonly included methicil-
lin-resistant S. aureus (MRSA) and extended spectrum
beta-lactamase/AmpC producing Enterobacteriaceae. The pur-
pose of activity was treatment and diagnosis (49%), treatment
alone (44%), diagnosis alone (5%), prevention (1%) or not
speciﬁed (2%). The majority of infections were community
TABLE 1. Hospital respondent characteristics
Total (n = 53) Australia (n = 40) New Zealand (NZ) (n = 11) Singapore (n = 2)
Number of inpatient beds
<200 10 8 2 0
200–500 25 20 5 0
500–1000 14 11 3 0
>1000 4 1 1 2
Setting
Metropolitan 41 32 7 2
Regional 12 8 4 0
Stafﬁng
ID Consultant FTE (median, IQR) 1.5 (0.5–3) 2 (0.5–3) 1 (0.75–2) 11 (10.5–11.5)a
ID trainees (median, IQR) 1 (0–1.5) 1 (0–1.5) 0 (0–1.5) 5.5 (5.25–5.75)a
Activity
Consultations per trainee per week (median, IQR)b 11.5 (9, 19) 12.5 (9, 19) 13 (9.6, 18.4) 8 (6, 9.9)a
Consultations per consultant per week (median, IQR) 8.2 (4.3, 14.25) 7.4 (4.2, 15) 10.5 (6.5, 17.5) 3.9 (3.6, 4.1)a
Funding
Private 4 4 0 0
Public 49 36 11 2
RACP training-accredited site
Yes 36 29 5 2
No 17 11 6 0
IQR, interquartile range; FTE, full-time equivalent.
aIQR represents quantity for each site in Singapore.
bOf 35 hospitals that had ID registrars (Australia n = 29, NZ n = 4, Singapore n = 2).
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onset, non-healthcare-associated (63%), rather than commu-
nity onset, healthcare associated (19%), nosocomial (16%) or
not speciﬁed (2%).The characteristics of the advice given by ID
physicians are provided in Table 4.
Discussion
We conducted this survey, the ﬁrst of its kind in these three
countries and the only large-scale study of the practice of
infectious diseases for more than 20 years [1], to provide a
snapshot to inform education and research priorities. We
found that the bulk of inpatient work still involves ‘bread and
butter’ conditions such as S. aureus infections, skin and soft
tissue infections and osteoarticular infections. However, a
striking ﬁnding was the long list of complex and uncommon
problems, including non-infectious conditions, infections in
immunocompromised hosts, infections involving prosthetic
material and multidrug-resistant pathogens.
Our study corroborates earlier data demonstrating that in
the regions surveyed ID inpatient activity is primarily consul-
tative rather than providing direct responsibility for patient
care [4]. Operational models of infectious diseases units vary
from consultation-only to those focused on inpatients (e.g.
those based around HIV, travel/immigrant or HITH services)
and this is likely to inﬂuence the distribution of case mix seen
by each unit. In Australia, where infectious diseases services
are relatively mature, most larger hospitals have a mix of both
consultations and inpatients, whereas in smaller hospitals
consultative services predominate. The broad spectrum of
referring departments is similar to that previously described in
Europe and North America and highlights the inter-disciplinary
nature of the speciality [2,6,7,10]. The relatively low propor-
tion of referrals from ICU may in part be explained by the
TABLE 2. Consultation activity characteristics
Setting Country
Total,
n = 1722 (%)
Metropolitan,
n = 1366 (%)
Regional,




n = 1241 (%)
New Zealand,
n = 310 (%))
Singapore,
n = 171 (%)
p
value
Most frequent referring departments
General medicine 324 (19) 222 (16) 102 (29) 0.001 226 (18) 71 (23) 27 (16) 0.10
Orthopaedic surgery 193 (11) 148 (11) 45 (13) 0.93 128 (10) 41 (13) 24 (14) 0.15
Emergency department 171 (10) 139 (10) 32 (9) 0.55 138 (11) 6 (2) 27 (16) <0.001
General surgery 92 (5) 76 (6) 16 (4) 0.79 68 (5) 24 (8) 0 (0) <0.001
Intensive care 85 (5) 70 (5) 15 (4) 0.58 62 (5) 21 (7) 2 (1) 0.015
Haematology 79 (5) 73 (5) 6 (2) 0.4 56 (5) 17 (5) 6 (4) 0.62
Cardiology 71 (4) 58 (4) 13 (4) 0.66 50 (4) 17 (5) 4 (2) 0.26
Renal 70 (4) 51 (4) 19 (5) 0.13 55 (4) 7 (2) 8 (5) 0.19
Oncology 57 (3) 51 (4) 6 (2) 0.13 37 (3) 8 (3) 12 (7) 0.03
Patient characteristics
HIV 67 (4) 62 (5) 5 (1) 0.005 42 (3) 9 (3) 16 (9) 0.002
Diabetes 323 (19) 256 (19) 67 (19) 0.65 210 (17) 46 (15) 67 (39) <0.001
IVDU 29 (2) 23 (2) 6 (2) 1 25 (2) 4 (1) 0 (0) 0.12
Travel related 65 (4) 60 (4) 5 (1) 0.088 43 (3) 11 (4) 11 (6) 0.18
Prosthetic material related 221 (13) 168 (12) 53 (15) 0.29 156 (13) 51 (16) 14 (8) 0.03
Immunosuppressed 361 (21) 318 (23) 43 (12) <0.001 218 (18) 67 (22) 76 (44) <0.001
Focus of infection
Skin/soft tissue 340 (20) 270 (20) 70 (20) 0.77 251 (20) 57 (18) 32 (19) 0.75
Respiratory 261 (15) 219 (16) 42 (12) 0.047 185 (15) 51 (16) 25 (15) 0.77
Bone/joint 243 (14) 183 (13) 60 (17) 0.39 182 (15) 46 (15) 15 (9) 0.10
Systemic 241 (14) 206 (15) 35 (10) 0.23 169 (14) 29 (9) 43 (25) <0.001
Non-infective 155 (9) 113 (8) 42 (12) 0.12 115 (9) 25 (8) 15 (9) 0.83
Intra-abdominal 136 (8) 113 (8) 23 (6) 0.27 93 (7) 26 (8) 17 (10) 0.47
Urinary 99 (6) 72 (5) 27 (8) 0.25 63 (5) 27 (9) 9 (5) 0.06
Cardiovascular 79 (5) 60 (4) 19 (5) 0.48 58 (5) 16 (5) 5 (3) 0.55
CNS 76 (4) 57 (4) 19 (5) 0.56 51 (4) 21 (6) 4 (2) 0.06
Othera 92 (5) 72 (5) 20 (6) 0.79 74 (6) 12 (4) 6 (4) 0.22
Suspected or conﬁrmed pathogenb
Bacterial 1034 (60) 819 (60) 215 (60) 0.68 750 (60) 217 (70) 67 (39) <0.001
Viral 101 (6) 87 (6) 14 (4) 0.045 71 (6) 10 (3) 20 (12) 0.001
Fungal 69 (4) 60 (4) 9 (3) 0.2 57 (5) 5 (2) 7 (4) 0.04
Mycobacterial 38 (2) 33 (2) 5 (1) 0.49 29 (2) 4 (1) 5 (3) 0.43
Parasitic 22 (1) 21 (2) 1 (0) 0.2 16 (1) 1 (0) 5 (3) 0.06
Multiresistant pathogens
MRSA 121 (7) 100 (7) 21 (6) 0.35 87 (7) 9 (3) 25 (15) <0.001
VRE 11 (1) 9 (1) 2 (1) 1 11 (1) 0 (0) 0 (0) 0.16
ESBL/AmpC producing
Enterobacteriaceae
82 (5) 70 (5) 12 (3) 0.1 37 (3) 17 (5) 28 (16) <0.001
CRE 5 (3) 4 (0) 1 (0) 1 4 (0) 1 (0) 0 (0) 1
Fluconazole resistant
Candida
9 (1) 9 (1) 0 (0) 0.22 8 (1) 0 (0) 1 (0) 0.45
MDR Tuberculosis 5 (0) 4 (0) 1 (0) 1 3 (0) 0 (0) 2 (1) 0.12
IVDU, intravenous drug use; CNS, central nervous system; VRE, vancomycin-resistant Enterococcus; ESBL, extended-spectrum beta-lactamase; CRE, carbapenem-resistant
enterobacteriaceae; MDR, Multidrug resistant.
aIncludes ear, nose and throat infections (n = 20), sexually transmitted infections (n = 4) and other infections non-speciﬁed (n = 68).
bFor some consultations a pathogen was not suspected/conﬁrmed.
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lower number of ICU beds in hospitals in our region [11], and
the provision of ID services on routine ICU rounds, which
were not included in this survey [12]. The value of targeted
interdepartmental collaborations involving ID physicians has
been shown, most speciﬁcally with regard to complex
infections involving prosthetic joints [13], cardiac valves [14]
and patients within either an internal medicine department
[15] or intensive care [16]. Thus, for departments that
frequently engage with ID physicians, collaboration in the
form of fellowships, multi-disciplinary meetings or co-location
of departments should be encouraged.
There appears to have been a shift from infections involving
the respiratory tract described historically, to infections
involving skin and soft tissue in this study [1,4,6,7,17,18]. This
may reﬂect the increasing rates of antibiotic resistance in
staphylococci (e.g. MRSA) and high prevalence of cutaneous
infections amongst the local indigenous Australian and New
Zealand populations [19]. The high proportion of non-infective
diagnoses in our study (9%) was similar to that found
elsewhere [4,6], highlighting the frequency with which
non-infectious syndromes may masquerade as infectious
diseases. Also notable was the long tail of infrequently
encountered pathogens, including 38 pathogen groups
reported less than ﬁve times each.
Similar to previous studies, bacterial pathogens were much
more common than infections involving viruses, fungi, myco-
bacteria and parasites [1,6]. This may reﬂect our focus on
inpatient rather than outpatient activities, where a greater
proportion of non-bacterial infections are encountered [1,20].
As with other studies, S. aureus was the most frequently
implicated pathogen [1,6], although the proportion that were
MRSA was higher than had been found in earlier studies [1].
Collectively, more than one in eight patients seen had an
infection that involved a multiresistant pathogen, indicative of
the emerging threat that antimicrobial resistance poses to
contemporary healthcare. Notably scarce or absent from the
list of pathogens were some that might be more frequently
encountered in Europe (e.g. Lyme disease; not reported) or
Africa and South America (e.g. schistosomiasis, ﬁlariasis,
trypanosomiasis or leishmaniasis; not reported). As the survey
was undertaken in the late temperate winter/tropical dry
season, the incidence of seasonal diseases (e.g. inﬂuenza,
rotavirus and melioidosis) may have been underestimated, as
may have non-bacterial pathogens for which sensitive diag-
nostic tests are less readily available.
Although treatment advice was the most frequent purpose
of activity, diagnostic assistance was sought in more than half of
all cases. Diagnostic advice was most frequently of a micro-
biological nature, but not infrequently related to radiological
imaging (17%), non-microbiology laboratory tests (6%) and
nuclear medicine imaging (1%). It is therefore important that
ID physicians be familiar with the limitations and potential risks
of such investigations. Input from an ID physician has been
shown to improve the appropriateness of antimicrobial use,
TABLE 3. Most frequently suspected/conﬁrmed pathogensa
Bacteria (n = 1249) Viruses (n = 104) Fungi (n = 79) Mycobacteria (n = 38) Parasites (n = 23)
S. aureus 409 Inﬂuenza 26 Candida 47 Mycobacterium tuberculosis 25 Plasmodium (non-falciparum) 7
Pseudomonas sp. 100 Dengue 16 Pneumocystis jirovecii 11 M. avium complex 7 Plasmodium (falciparum) 5
Escherichia coli 99 Herpes simplex virus 13 Aspergillus 9 Rapid growing mycobacteria 3 Sarcoptes scabiei 3
Enterobacteriaceae (other)b 86 Cytomegalovirus 10 Cryptococcus 3 Mycobacterium (other) 2 Echinococcus 3
Anaerobesc 74 Enteroviruses 8 Dermatophytes 3 M. ulcerans 1 Entamoeba histolytica 2
Group A streptococci 67 Respiratory syncytial virus 6 Zygomycetes 2 Cryptosporidium 1
Coagulase-negative staphylococci 67 Varicella zoster virus 6 Scedosporium 1 Giardia 1
Enterococcus sp. 66 Hepatitis B 5 Dimorphic fungi 1 Lice/Pediculosis 1
Streptococcus pneumoniae 57 Hepatitis C 3 Fusarium 1
Klebsiella sp. 54 Epstein-Barr virus 3 Yeast not speciﬁed 1
Other bacteriad 170 Other virusese 8
aRespondents reported >1 pathogen in the event of polymicrobial infection.
bIncludes Enterobacter sp.( n = 21), non-typhoidal Salmonella (n = 8), Salmonella typhi (n = 5), Serratia sp. (n = 2), Proteus sp. (n = 1), other Enterobacteriaceae not-speciﬁed
(n = 49).
cIncludes Clostridium difﬁcile (n = 21), Clostridium sp. (n = 6), other anaerobes not-speciﬁed (n = 47).
dIncludes Viridans streptococci (n = 46), Group B streptococci (n = 23), Group C/G streptococci (n = 21), Haemophilus inﬂuenzae (n = 20), Neisserria meningitidis (n = 16),
Stenotrophomonas maltophilia (n = 8), Chlamydia sp. (n = 4), Acinetobacter sp. (n = 4),Mycoplasma sp. (n = 4), Nocardia sp. (n = 3), Rickettsia sp. (n = 3),Moraxella sp. (n = 3), Listeria
sp. (n = 3), Kingella sp. (n = 3), Burkholderia pseudomallei (n = 3), Coxiella burnetii (n = 2), N. gonorrhoeae (n = 2), Bacillus sp. (n = 1), Legionella sp. (n = 1).
eIncludes rhinovirus (n = 3), adenovirus (n = 2), poxvirus (n = 1), measles virus (n = 1), human metapneumovirus (n = 1).
TABLE 4. Advice given by ID physicians
n (%)
Antimicrobial advice 1655 (96)
Start 259 (15)
Stop 121 (7)
Change (escalate) 398 (23)
Change (de-escalate) 314 (18)
Continue same 477 (28)
Continue to withhold 86 (5)
Diagnostic advice 712 (41)
Microbiological 286 (17)
Pathology (non-microbiological) 108 (6)
Radiological 293 (17)
Nuclear medicine 25 (1)
Surgical procedure 161 (9)
Non-antimicrobial medication advice 45 (3)
Immunization advice 30 (2)
Infection control advice 61 (4)
Other 144 (8)
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minimize costs and reduce rates of antibiotic resistance
[16,21,22]. Although compliance with, and the subsequent
impact of, ID involvement was not assessed in our study, 30%
of all advice was to cease, withhold or de-escalate antimicro-
bial therapy, emphasizing the important role ID physicians play
in preserving limited antimicrobial resources.
The number of consultative episodes and breadth of
practice settings encompassed within our survey enabled us
to identify variations in practice between different geograph-
ical settings and hospital types. Although there was variation
in the source of referral of patients, the foci of infection were
relatively similar between geographical settings, as in a
previous study [1]. However the patient characteristics and
prevalence of multiresistant pathogens differed, with metro-
politan hospitals having a higher proportion of HIV positive
and immunosuppressed patients, and multiresistant pathogens
being more frequently encountered in Singapore. Despite
small numbers of private hospitals participating in our survey,
we demonstrated that, contrary to a previous North
American study [6], consultative activity in private hospitals
differs signiﬁcantly from that in the public setting. Paediatric
patients tended to have more systemic infections and
infections of viral aetiology, with a smaller proportion having
co-morbidities.
Our data provided a unique opportunity to validate the
Royal Australasian College of Physicians Infectious Diseases
training curriculum and could be utilized in the same manner
by other bodies overseeing infectious diseases curriculum
design such as the Union of European Medical Specialists
(UEMS).
The large number of contributing sites across three
countries, including the majority of ID training sites, improves
the generalizability of our ﬁndings. Although referral practices
may differ in other regions, we note that the most frequent
referring disciplines in our study were similar to those
described in earlier studies from both Europe and North
America [7,10,23]. Formal infectious diseases consultative
activity in developing countries may differ signiﬁcantly. For
example, between 2008 and 2011 at a South African tertiary
hospital, 80% of consultations involved HIV-positive patients,
and tuberculosis and malaria were the most frequent diagnoses
amongst patients without HIV [24]. We acknowledge certain
factors may bias our results, including seasonality and
non-participation, particularly of physicians in private hospitals.
Finally, our study only examined formal inpatient activity as this
forms the bulk of an ID physician’s work [18]. The spectrum of
disease encountered in the outpatient setting or during
informal consultations is characterized by less severe disease,
with a greater proportion of gastro-intestinal and urinary tract
disease, viral and parasitic infections, prophylaxis, and travel
and sexual health related issues [1–3,20]. This is likely to at
least partly explain the low proportion of patients with HIV
and other viral infections (e.g. viral hepatitis). We recognize
that, in addition to providing consultative clinical advice, an ID
physician has numerous other equally important roles in the
realms of research and teaching, infection control, administra-
tion and antimicrobial stewardship [18,21,25]. Hence these
data should not be used to infer how busy or valuable ID
physicians are, but rather the breadth of their inpatient-based
practice.
In conclusion, we have performed a tri-national survey of ID
physicians and found that the scope of ID inpatient activity is
diverse and differs between practice settings. Since the
completion of our study, the ASID Clinical Research Network
(CRN) has selected staphylococcal bacteraemia, prosthetic
joint infections, diabetic foot infections and infections involving
immunosuppressed hosts as areas of high priority for collab-
orative research activity [26], planning for which is currently
underway. The rotation of ID registrars between geographical
areas, and between metropolitan and regional hospitals, will
ensure training in the full breadth of infectious diseases.
Further work is required in exploring the range of ID practice
outside of inpatient settings, whilst periodic surveys such as
these are required to monitor changes in training and research
priorities.
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